Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutation.

We examined the type I collagen synthesized by cultured dermal fibroblasts from a patient affected with osteogenesis imperfecta (OI) type IV. Both normal and abnormal trimers were produced. The mutant collagen molecules were excessively modified intracellularly, had a melting temperature 4 degrees C lower than the control, were secreted at a reduced rate, and underwent delayed processing to mature alpha chains.Molecular investigations identified a G --> A transition in one COL1A2 allele, resulting in a Gly922 --> Ser substitution in the alpha2(I) chain. The proband's mutation was demonstrated to arise "de novo" by the absence of the mutant allele restriction enzyme pattern from parental genomic DNA.We analyzed the insoluble extracellular matrix deposited by long-term cultured fibroblasts from our patient and from a previously described unrelated individual who carries an identical substitution. In both cases, the mutant chain constituted 10-15% of the total alpha chains deposited.We also present here the first detailed comparison of phenotype between unrelated OI patients with an identical collagen mutation. These two patients are both Caucasian females, ages 8 and 9 years, each diagnosed as type IV OI by the Sillence classification. They have a similar phenotype including moderate skeletal fragility with several femur fractures, dentinogenesis imperfecta, wormian bone, and reduced height and weight. We conclude that this phenotype is related both to the location of this mutation and to the similar extent of matrix incorporation by the mutant chains. Molecular and biochemical studies of unrelated individuals with identical amino acid substitutions in type I collagen resulting in either similar or dissimilar clinical outcomes will make a significant contribution to identifying the factors involved in the modulation of the OI phenotype.

[1]  Raymond Dalgleish,et al.  The human type I collagen mutation database , 1997, Nucleic Acids Res..

[2]  H. Kresse,et al.  Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta. , 1996, American journal of medical genetics.

[3]  H. Kuivaniemi,et al.  Direct sequencing of PCR products derived from cDNAs for the proα1 and proα2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta , 1996 .

[4]  P. Pignatti,et al.  Severe (type III) osteogenesis imperfecta due to glycine substitutions in the central domain of the collagen triple helix. , 1994, Human molecular genetics.

[5]  J. Bateman,et al.  Deposition and selective degradation of structurally-abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[6]  P. Byers,et al.  A Gly859Ser substitution in the triple helical domain of the α2 chain of type I collagen resulting in osteogenesis imperfecta type III in two unrelated individuals , 1994, Human mutation.

[7]  P. Byers,et al.  An RT-PCR-SSCP screening strategy for detection of mutations in the gene encoding the alpha 1 chain of type I collagen: application to four patients with osteogenesis imperfecta. , 1993, Human molecular genetics.

[8]  F. Glorieux,et al.  Identification of type I collagen gene (COL1A2) mutations in nonlethal osteogenesis imperfecta. , 1993, Human molecular genetics.

[9]  A. Forlino,et al.  Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. , 1993, Matrix.

[10]  J. Marini,et al.  Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology. , 1993, The Journal of biological chemistry.

[11]  P. Pignatti,et al.  Paternal mosaicism for a COL1A1 dominant mutation (α1 Ser‐415) causes recurrent osteogenesis imperfecta , 1993, Human mutation.

[12]  W. Cole,et al.  Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity. , 1992, The Biochemical journal.

[13]  P. Byers,et al.  Osteogenesis imperfecta: translation of mutation to phenotype. , 1991, Journal of medical genetics.

[14]  W. Cole,et al.  Characterization of a type I collagen alpha 2(I) glycine-586 to valine substitution in osteogenesis imperfecta type IV. Detection of the mutation and prenatal diagnosis by a chemical cleavage method. , 1991, The Biochemical journal.

[15]  H. Kuivaniemi,et al.  Mutations in collagen genes: causes of rare and some common diseases in humans , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  P. Pignatti,et al.  A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. , 1991, The Journal of biological chemistry.

[17]  J. Engel,et al.  The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. , 1991, Annual review of biophysics and biophysical chemistry.

[18]  P. Marynen,et al.  Rapid detection of hypervariable regions by the polymerase chain reaction technique. , 1990, DNA and cell biology.

[19]  J. Bateman,et al.  Assessment of procollagen processing defects by fibroblasts cultured in the presence of dextran sulphate. , 1990, The Biochemical journal.

[20]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Sillence.  Osteogenesis Imperfecta Nosology and Genetics , 1988, Annals of the New York Academy of Sciences.

[22]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[23]  D. Prockop,et al.  Proteolytic enzymes as probes for the triple-helical conformation of procollagen. , 1981, Analytical biochemistry.